Parkinson’s group to weigh benefits, risks of participating in clinical trials
CAMDEN — At the next meeting of the Camden-based Parkinson's Support Group, set for Tuesday, August 7, group member Frank Mundo will talk about his experience as a participant in clinical drug trials and discuss some of the issues one should consider before deciding whether to participate in drug studies. The meeting will begin at 12 p.m. with Mundo's presentation and continue until 2 p.m. with attendees separating into smaller groups for discussion. Anyone living with Parkinson's, as well as their family members and caregivers, is welcome to attend.
Supplementing his personal account with insights gleaned from his research on the topic, Mundo will explain how clinical trials are conducted and how study participants may be affected, medically and otherwise. He'll also touch on the directions science is now taking in the fight against Parkinson's disease.
"Everyone with Parkinson's has a stake in what's to be achieved through drug-therapy research, but participating in trials is not for everyone," says Mundo. "People need to understand the issues so they can make informed decisions for themselves."
The Camden-based support group meets regularly at Quarry Hill on the first Tuesday of each month from noon to 2 p.m. For more information about the August meeting or about the group in general, please contact Cassie Walters, (207) 596-3978 or firstname.lastname@example.org.